Amyloid Self-Assembly of hIAPP8-20 via the Accumulation of Helical Oligomers, α-Helix to β-Sheet Transition, and Formation of β-Barrel Intermediates.


Journal

Small (Weinheim an der Bergstrasse, Germany)
ISSN: 1613-6829
Titre abrégé: Small
Pays: Germany
ID NLM: 101235338

Informations de publication

Date de publication:
05 2019
Historique:
received: 05 12 2018
revised: 21 02 2019
pubmed: 26 3 2019
medline: 29 8 2020
entrez: 26 3 2019
Statut: ppublish

Résumé

The self-assembly of human islet amyloid polypeptide (hIAPP) into β-sheet-rich nanofibrils is associated with the pathogeny of type 2 diabetes. Soluble hIAPP is intrinsically disordered with N-terminal residues 8-17 as α-helices. To understand the contribution of the N-terminal helix to the aggregation of full-length hIAPP, here the oligomerization dynamics of the hIAPP fragment 8-20 (hIAPP8-20) are investigated with combined computational and experimental approaches. hIAPP8-20 forms cross-β nanofibrils in silico from isolated helical monomers via the helical oligomers and α-helices to β-sheets transition, as confirmed by transmission electron microscopy, atomic force microscopy, circular dichroism spectroscopy, Fourier transform infrared spectroscopy, and reversed-phase high performance liquid chromatography. The computational results also suggest that the critical nucleus of aggregation corresponds to hexamers, consistent with a recent mass-spectroscopy study of hIAPP8-20 aggregation. hIAPP8-20 oligomers smaller than hexamers are helical and unstable, while the α-to-β transition starts from the hexamers. Converted β-sheet-rich oligomers first form β-barrel structures as intermediates before aggregating into cross-β nanofibrils. This study uncovers a complete picture of hIAPP8-20 peptide oligomerization, aggregation nucleation via conformational conversion, formation of β-barrel intermediates, and assembly of cross-β protofibrils, thereby shedding light on the aggregation of full-length hIAPP, a hallmark of pancreatic beta-cell degeneration.

Identifiants

pubmed: 30908844
doi: 10.1002/smll.201805166
pmc: PMC6499678
mid: NIHMS1020303
doi:

Substances chimiques

Amyloid 0
Islet Amyloid Polypeptide 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1805166

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM119691
Pays : United States

Informations de copyright

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

J Biol Chem. 2000 May 12;275(19):14077-83
pubmed: 10799482
N Engl J Med. 2000 Aug 10;343(6):411-9
pubmed: 10933741
J Mol Biol. 2002 May 3;318(3):863-76
pubmed: 12054829
J Struct Biol. 2003 Mar;141(3):218-27
pubmed: 12648568
J Clin Endocrinol Metab. 2004 Aug;89(8):3629-43
pubmed: 15292279
J Mol Biol. 2004 Aug 27;341(5):1175-87
pubmed: 15321714
Diabetes. 2004 Dec;53 Suppl 3:S233-8
pubmed: 15561917
Biochemistry. 2006 Aug 8;45(31):9496-508
pubmed: 16878984
Methods Enzymol. 2006;412:314-38
pubmed: 17046666
Protein Sci. 2007 Jan;16(1):110-7
pubmed: 17123962
Biophys J. 2007 Jun 1;92(11):4064-77
pubmed: 17307823
Chem Soc Rev. 2007 Aug;36(8):1263-9
pubmed: 17619686
Proteins. 2008 Apr;71(1):207-14
pubmed: 17932914
Biochemistry. 2007 Nov 27;46(47):13505-22
pubmed: 17979302
J Phys Chem B. 2008 Apr 10;112(14):4410-8
pubmed: 18341325
Mol Med. 2008 Jul-Aug;14(7-8):451-64
pubmed: 18368143
RNA. 2008 Jun;14(6):1164-73
pubmed: 18456842
Protein Sci. 2008 Sep;17(9):1467-74
pubmed: 18556473
Bioinformatics. 2008 Sep 1;24(17):1951-2
pubmed: 18579566
Structure. 2008 Jul;16(7):1010-8
pubmed: 18611374
Biochemistry. 2008 Sep 16;47(37):9900-10
pubmed: 18710262
J Am Chem Soc. 2008 Nov 12;130(45):14990-5001
pubmed: 18937465
Biochemistry. 2008 Dec 2;47(48):12689-97
pubmed: 18989932
Phys Biol. 2009 Feb 10;6(1):015005
pubmed: 19208933
J Biol Chem. 2009 May 1;284(18):11982-91
pubmed: 19244249
Annu Rev Biophys. 2009;38:125-52
pubmed: 19416063
Protein Sci. 2009 Jul;18(7):1521-30
pubmed: 19475663
J Mol Biol. 2009 Oct 23;393(2):383-96
pubmed: 19647750
J Am Chem Soc. 2009 Dec 30;131(51):18283-92
pubmed: 19950949
Chem Rev. 2010 Aug 11;110(8):4820-38
pubmed: 20402519
J Chem Phys. 2010 Apr 28;132(16):165103
pubmed: 20441311
Chem Soc Rev. 2010 Sep;39(9):3480-98
pubmed: 20498896
Analyst. 2011 Jan 7;136(1):20-8
pubmed: 20820495
J Am Chem Soc. 2010 Oct 6;132(39):13765-75
pubmed: 20828131
J Am Chem Soc. 2010 Dec 29;132(51):18223-32
pubmed: 21138275
Clin Chim Acta. 2011 Apr 11;412(9-10):785-7
pubmed: 21219896
Nat Chem. 2011 Feb;3(2):172-7
pubmed: 21258392
J Am Chem Soc. 2011 May 18;133(19):7240-3
pubmed: 21517093
J Biol Chem. 2011 Jul 8;286(27):23959-66
pubmed: 21566116
Physiol Rev. 2011 Jul;91(3):795-826
pubmed: 21742788
J Mol Biol. 2012 Aug 10;421(2-3):390-416
pubmed: 22326493
Science. 2012 Mar 9;335(6073):1228-31
pubmed: 22403391
ACS Nano. 2012 May 22;6(5):3907-18
pubmed: 22468743
Biochemistry. 2012 May 1;51(17):3694-703
pubmed: 22486153
J Phys Chem B. 2013 Sep 5;117(35):10149-60
pubmed: 23926957
Biomacromolecules. 2014 Jan 13;15(1):122-31
pubmed: 24313776
Biochim Biophys Acta. 2014 Dec;1838(12):3162-70
pubmed: 25218343
J Phys Chem B. 2015 Feb 26;119(8):3366-76
pubmed: 25646717
Sci Rep. 2015 Feb 04;5:8240
pubmed: 25649462
Nat Struct Mol Biol. 2015 Jun;22(6):499-505
pubmed: 25938662
Biomacromolecules. 2015 Sep 14;16(9):2940-9
pubmed: 26301845
Angew Chem Int Ed Engl. 2015 Nov 23;54(48):14383-7
pubmed: 26440575
Curr Opin Struct Biol. 2016 Apr;37:9-13
pubmed: 26638022
J Am Chem Soc. 2016 Jan 20;138(2):549-57
pubmed: 26700445
Sci Rep. 2016 Jan 14;6:19463
pubmed: 26763863
ACS Chem Neurosci. 2016 Mar 16;7(3):286-96
pubmed: 26815332
Nat Struct Mol Biol. 2016 May;23(5):409-15
pubmed: 27018801
Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10866-71
pubmed: 27621459
J Phys Chem B. 2016 Nov 23;120(46):11905-11911
pubmed: 27785911
Elife. 2017 Jan 03;6:
pubmed: 28045370
J Chem Theory Comput. 2017 Mar 14;13(3):1454-1461
pubmed: 28157327
Sci Rep. 2017 Mar 13;7:44041
pubmed: 28287098
Chem Soc Rev. 2017 Oct 30;46(21):6492-6531
pubmed: 28702523
Phys Chem Chem Phys. 2017 Oct 25;19(41):28414-28423
pubmed: 29038815
Biomacromolecules. 2017 Dec 11;18(12):4316-4322
pubmed: 29095600
Elife. 2017 Nov 17;6:
pubmed: 29148426
Biochim Biophys Acta Biomembr. 2018 Mar 14;1860(9):1687-1697
pubmed: 29550287
Chem Sci. 2017 Nov 3;9(2):463-474
pubmed: 29619202
Sci Rep. 2018 Jul 9;8(1):10353
pubmed: 29985420
J Am Chem Soc. 2019 Feb 6;141(5):1941-1948
pubmed: 30621387
Biopolymers. 1983 Dec;22(12):2577-637
pubmed: 6667333
Fold Des. 1998;3(6):577-87
pubmed: 9889167

Auteurs

Yunxiang Sun (Y)

Department of Physics, Ningbo University, Ningbo, 315211, China.
Department of Physics and Astronomy, Clemson University, Clemson, SC, 29634, USA.

Aleksandr Kakinen (A)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia.

Yanting Xing (Y)

Department of Physics and Astronomy, Clemson University, Clemson, SC, 29634, USA.

Pouya Faridi (P)

Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3800, Australia.

Aparna Nandakumar (A)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia.

Anthony W Purcell (AW)

Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, 3800, Australia.

Thomas P Davis (TP)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia.

Pu Chun Ke (PC)

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia.

Feng Ding (F)

Department of Physics and Astronomy, Clemson University, Clemson, SC, 29634, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH